Stanford Cancer Institute
Translating Stanford discoveries into individualized cancer care
White House Challenge to End Hunger and Build Healthy Communities
SCI member Lisa Goldman Rosas, PhD, MPH, and Instacart has risen to the Challenge to examine the impact of nutrition security interventions.
In Vivo Tracking of Chimeric Antigen Receptor T-Cells
Postdoc Wei (Emma) Wu, PhD, and team describe their recent study working with iron oxide nanoparticles as CAR T-cell trackers.
Colorectal cancer: Recent research and insight
In observance of Colorectal Cancer Awareness Month we talked to SCI members George A. Fisher Jr., MD, and Steven M. Corsello, MD.
The Future of Cancer
The SCI is focused on pushing the limits of what we can do and what we know. The only way to really advance our knowledge is to push forward in laboratories, keep thinking about novel approaches, novel mechanisms. We cannot stand still!
National Cancer Institute Designation
The Stanford Cancer Institute has been designated a Comprehensive Cancer Center by the National Cancer Institute, a part of the National Institutes of Health and the world’s leading cancer research organization.
Designation as a Comprehensive Cancer Center signifies that the Stanford Cancer Institute maintains the highest level of scientific rigor, institutional support and coordination for the complete range of cancer-related research, including basic, translational, clinical and population-based science. The designation is recognition of the institute’s robust and integrated programs encompassing laboratory research, clinical care and community outreach and education.
The Institute’s mission is to support and coordinate the wide range of cancer-related activities — in basic, translational, clinical and population-based science — occurring at Stanford University, Stanford Health Care and Lucile Packard Children’s Hospital Stanford. Its over 450 members include scientists and physicians from a wide range of disciplines, all collaborating to translate research advances into improved cancer treatments.
Going to the dark(er) side: Stanford Medicine study shows how cancer gene tricks immune cells
A novel Stanford School of Medicine partnership uncovers a direct link between a cancer-associated gene, Myc, and sugar patterns on cancer cell surfaces that tell immune cells to stand down.
Stanford Medicine scientists transform cancer cells into weapons against cancer
Researchers found that when they turned cancer cells into immune cells, they were able to teach other immune cells how to attack cancer.
Black-sheep immune cells activated to eliminate tumors in laboratory mice
Neutrophils often suppress the immune system’s response to cancer, but when activated, they eliminate several types of tumors in laboratory mice, a study led by Stanford Medicine has found.
Stanford University and The Invus Group collaborate to develop glioblastoma drugs
The collaboration will enable the development of medications to treat a type of brain cancer.
Cancer Clinical Trials
Stanford Cancer Institute offers leading edge research and compassionate care with over 250 actively recruiting clinical trials, investigating a broad spectrum of new diagnostic, prevention and treatment strategies.